Pharmafile Logo
Pharmafocus logo
Advanced Search

arGEN-X

Showing 3 posts of 3 posts found.

arGEN-X appoints Evotec chief executive

April 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evotec, arGEN-X, lanthaler

Belgium-based clinical stage human therapeutic antibody firm arGEN-X has appointed Dr Werner Lanthaler to its supervisory board.
  Lanthaler is currently …

Appointment

arGEN-X appoints Alain Thibault as its new chief medical officer

March 19, 2012
Sales and Marketing Alain Thibault, Regeneron, arGEN-X

arGEN-X, a biopharma firm focused on the discovery and development of human monoclonal antibodies, has appointed Alain Thibault as the …

Appointment

Shire signs antibody research deal with arGEN-X

February 29, 2012
Research and Development Shire, arGEN-X, monoclonal antibodies

Shire has signed a deal with antibody specialists arGEN-X to develop drugs for rare genetic diseases.Rotterdam-based arGEN-X will use its …

News
The Gateway to Local Adoption Series

Latest content

Care Quality Commission appoints Emily Miles as Chief Executive

July 17, 2026

National survey aims to improve glaucoma care across the UK

July 16, 2026

Phase 3 trials support expanded use of Dysport for migraine prevention

July 15, 2026

Roche secures CE Mark for automated latent tuberculosis blood test

July 14, 2026

ReproNovo Phase 2 fertility study doses first participant

July 10, 2026